Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
MGNX
#3585
MacroGenics, Inc.
3.4
9
USD
+0.58%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.58%
Aylık Değişim
+15.18%
6 aylık değişim
+115.43%
Yıllık Değişim
+166.41%
Önceki Kapanış
3.4
7
Open
3.4
9
Bid
Ask
Low
3.4
9
High
3.4
9
Hacim
80
Piyasalar
ABD Borsası
Sağlık Hizmetleri
MGNX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
56.26 M
61.32 M
61.84 M
62.43 M
63.09 M
63.56 M
—
Valuation ratios
Enterprise value
1.1 B
860.79 M
284.41 M
534.6 M
22.2 M
45.11 M
-48.4 M
Price to earnings ratio
—
-4.76
-3.26
-67.87
-3.04
-1.36
-6.38
Price to sales ratio
—
12.42
2.57
10.73
1.36
0.68
2.49
Price to cash flow ratio
—
-6.69
-4.49
-8.06
-2.98
-1.25
-4.11
Price to book ratio
—
4.02
2.75
4.13
1.75
1.83
2.6
Enterprise value to EBITDA ratio
-9.28
-4.49
-2.6
-3.37
-0.22
-0.69
0.55
Profitability ratios
Return on assets %
-0.34
-0.6
-0.43
-0.03
-0.26
-0.29
-0.32
Return on equity %
-0.44
-0.84
-0.84
-0.06
-0.58
-1.34
-1.3
Return on invested capital %
-338.26
-510.33
-323.56
-442.07
-386.54
-242.7
-426.39
Gross margin %
100
96.58
97.79
98.95
99.44
100
400
Operating margin %
-124.96
-261.85
-79.91
-286.38
-73.74
-48.72
-492.13
EBITDA margin %
-113.56
-247.31
-72.1
-269.96
-68.71
-43.93
-463.54
Net margin %
-123.7
-260.97
-78.82
-15.42
-44.66
-49.91
-485.3
Liquidity ratios
Quick ratio
—
3.69
4.54
4.46
3.92
4.92
18.07
Current ratio
6.17
3.75
4.57
4.48
3.92
5.1
18.86
Inventory turnover
—
0.6
1.15
0.46
1.39
0
0
Asset turnover
0.3
0.22
0.49
0.2
0.54
0.58
0.59
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.4
-1.42
-1.26
-1.09
-1.28
-1.28
EBIT per share
—
-3.38
-1.98
-2.72
-1.77
-1.15
-1.16
EBITDA per share
—
-3.2
-1.78
-2.56
-1.65
-1.04
-1.04
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
2.06
1.77
1.63
2.92
0.91
6.55
Net current asset value per share
—
4.66
3.62
4.06
3.47
3.48
13.29
Tangible book value per share
—
4
2.31
2.46
1.85
0.88
3.93
Working capital per share
—
3.42
2.83
3.15
2.59
2.8
10.4
Book value per share
—
4
2.31
2.46
1.85
0.88
3.93
Haberler
MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX)
B.Riley, ADAM9 ADC potansiyeli nedeniyle MacroGenics hissesini yükseltti
MacroGenics kanser çalışmasında kayıtlara yeniden başladı
MacroGenics 2026’da stratejik dönüş planlıyor
MacroGenics at The Citizens Life Sciences Conference: Strategic Reemergence in 2026
MacroGenics Leerink Konferansı’nda stratejik portföyünü açıkladı
MacroGenics at Leerink Global Healthcare Conference: Strategic Pipeline Focus
Stifel, MacroGenics hissesi için 4 dolar hedef fiyatını korudu
Stifel reiterates MacroGenics stock rating with $4 price target
MacroGenics Inc kazancı $0,03 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek
MacroGenics Inc earnings missed by $0.03, revenue topped estimates
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates